A pinch of salt - A podcast by ERA
by European Renal Association
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 4 chart positions in 4 markets.
By chart position
- 🇮🇪IE · Medicine#783K to 10K
- 🇷🇴RO · Medicine#141500 to 3K
- 🇩🇰DK · Medicine#146500 to 3K
- 🇬🇷GR · Medicine#155500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.4K to 5.7K🎙 Daily cadence·124 episodes·Last published yesterday - Monthly Reach
Unique listeners across all episodes (30 days)
4.5K to 19K🇮🇪53%🇷🇴16%🇩🇰16%+1 more - Active Followers
Loyal subscribers who consistently listen
1.4K to 5.7K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 17 epsHosts
Recent guests
Recent episodes
Trailer Osteoporosis in CKD: when bone and kidneys disagree?, European Specialty Examination in Nephrology: demystifying the ESENeph and Diuretics in Acute Heart Failure: take them with a “pinch of salt”?
Sep 3, 2026
1m 07s
#77 Generative AI for the busy nephrologist: adapt or perish? with Wisit Cheungpasitporn
Jun 18, 2026
48m 28s
#76 Late Breakers, LIVE from Glasgow, with Alberto Ortiz and Danilo Fliser
Jun 18, 2026
31m 00s
#78 B-cell therapy in IgA Nephropathy: worth the hype? with Vlado Perkovic
Jun 18, 2026
36m 17s
Trailer Late Breakers, LIVE from Glasgow, Generative AI for the busy nephrologist: adapt or perish? and B-cell therapy in IgA Nephropathy: worth the hype?
Jun 11, 2026
1m 11s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 9/3/26 |  Trailer Osteoporosis in CKD: when bone and kidneys disagree?, European Specialty Examination in Nephrology: demystifying the ESENeph and Diuretics in Acute Heart Failure: take them with a “pinch of salt”? | No description provided. | 1m 07s | ||||||
| 6/18/26 | Generative AInephrology+3 | Wisit Cheungpasitporn | European Renal Association | — | Generative AInephrologist+5 | — | 48m 28s | ||
| 6/18/26 | nephrologyCKD drug class+3 | Alberto OrtizDanilo Fliser | nurandociguatsemaglutide+3 | — | nephrologyCKD+3 | — | 31m 00s | ||
| 6/18/26 | IgA NephropathyB-cell therapy+4 | Vlado Perkovic | anti-APRILanti-BAFF+3 | — | IgA nephropathyB-cell therapy+7 | — | 36m 17s | ||
| 6/11/26 | nephrologygenerative AI+3 | — | European Renal AssociationGenerative AI for the busy nephrologist: adapt or perish?+1 | Glasgow | nephrologygenerative AI+4 | — | 1m 11s | ||
| 5/14/26 | Aldosterone Synthase InhibitionMRAs+4 | Maria Jose Soler Romeo | European Renal Association | — | aldosteroneMRAs+5 | — | 17m 57s | ||
| 5/14/26 | narrative-based medicinepatient-friendly clinical medicine+3 | Amy Waterman | European Renal Association | — | narrative-based medicinepatient perspective+3 | — | 39m 12s | ||
| 5/14/26 | Chronic Kidney Diseaseinflammation+4 | Peter Stenvinkel | European Renal AssociationChronic Kidney Disease | — | Chronic Kidney Diseaseinflammation+5 | — | 25m 32s | ||
| 5/7/26 | Aldosterone SynthaseNephrology+5 | — | European Renal AssociationTrailer Inhibition of Aldosterone Synthase and MRAs in Nephrology, Inflammation and Aging in CKD – From Translational Basics to Clinical Practice, What is narrative-based medicine? | — | aldosteronenephrology+5 | — | 2m 26s | ||
| 4/16/26 | liquid biopsiesartificial intelligence+4 | Valentin Goutaudier | European Renal Association | — | liquid biopsiesAI+4 | — | 28m 07s | ||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/16/26 | Peritoneal Dialysischallenges in healthcare+3 | Karlien François | European Renal AssociationPeritoneal Dialysis+1 | — | Peritoneal Dialysischronic kidney disease+3 | — | 31m 20s | ||
| 4/16/26 | Peritoneal Dialysiscomplications+3 | Sana F. Khan | European Renal Association | — | Peritoneal Dialysiscomplications+3 | — | 27m 22s | ||
| 4/9/26 | Peritoneal Dialysiscomplications+4 | — | European Renal Association | — | Peritoneal Dialysiscomplications+5 | — | 1m 36s | ||
| 3/12/26 | frailtysarcopenia+4 | Thomas Wilkinson | European Renal Association | — | sarcopeniafrailty+5 | — | 25m 00s | ||
| 3/12/26 | vascular accesshealthcare innovations+3 | Tamara Jemcov | Vascular Access Society | Padova | vascular accessTamara Jemcov+4 | — | 21m 15s | ||
| 3/12/26 | extracorporeal adsorption techniquesICU patients+3 | Thomas Rimmele | European Renal Association | — | extracorporeal adsorptionICU+3 | — | 29m 37s | ||
| 3/5/26 | extracorporeal adsorptionICU patients+4 | — | European Renal AssociationTrailer Extracorporeal adsorption techniques in ICU patients – when to say yes, when to suggest no?+2 | — | extracorporeal adsorptionICU+5 | — | 2m 23s | ||
| 2/12/26 | patient-reported outcomesclinical practice+3 | Paul Cockwell | European Renal Association | — | patient-reported outcomesclinical practice+3 | — | 33m 59s | ||
| 2/12/26 |  #65 About the GFR formulas – How to measure renal function in 2026? with Pierre Delanaye | In this episode of A pinch of salt, we welcome Pierre Delanaye for a forward-looking discussion on how we should assess kidney function in 2026. Together, we explore the strengths and limits of today’s GFR equations (MDRD, CKD-EPI, cystatin C-based approaches), the promise of emerging biomarkers and AI-driven tools, and the crucial question of fairness and accuracy across diverse populations. | 25m 36s | ||||||
| 2/12/26 |  #64 Evolution of Treatment Paradigms in ANCA Vasculitis, with David Jayne | Join A pinch of salt, as we sit down with David Jayne to trace the rapid transformation of ANCA-associated vasculitis care. From the historic cyclophosphamide–glucocorticoid backbone to biologics like rituximab and newer targeted strategies such as complement inhibition (including avacopan), this episode unpacks how clinicians can balance efficacy, safety, and quality of life—while looking ahead to what may define the next decade of treatment. | 20m 50s | ||||||
| 2/5/26 | Trailer Evolution of Treatment Paradigms in ANCA Vasculitis, About the GFR formulas – How to measure renal function in 2026? and Patient-reported outcomes in clinical practice | No description provided. | 1m 27s | ||||||
| 1/15/26 |  #63 Treatment of obesity in patients with CKD, with Allon N. Friedman | In this episode of A pinch of salt, Allon N. Friedman will talk about possibly the hottest topic in medicine at this moment – the treatment of obesity, with a particular focus on treating the CKD population. Obesity is finally being recognized as a disease and not merely an unfortunate, somewhat shameful consequence of personalities with weak minds and lack of willpower. But how do we treat it? Does changing lifestyle have any impact, should everybody start taking weight lowering medications,... | 33m 59s | ||||||
| 1/15/26 |  #62 Chronic kidney disease of unknown etiology, with Shuchi Anand | In this episode of A pinch of salt, Shuchi Anand will talk about chronic kidney disease of unknown etiology, the mysterious kidney disease that is devastating some agricultural communities in hot environments. Dr Anand will talk about what might be causing this disease, does a kidney biopsy help, is it mandatory, and how to treat these patients both on the individual level and on the population level to tackle this disease locally and globally. Learn more about this true medical mystery, with... | 32m 38s | ||||||
| 1/15/26 |  #61 Tubulointerstitial nephritis – the Cinderella of nephrology, with Beatriz Sanchez Alamo | In this episode of A pinch of salt, Beatriz Sanchez Alamo will talk about tubulointerstitial nephritis (TIN), the Cinderella of nephrology, a beautiful and interesting topic that is not easily noticeable in congresses and webinars. Some recent data looking at long-term prognosis has shown that patients with TIN might have a long-term prognosis that is comparable to lupus nephritis and ANCA vasculitis. Are we ignoring TIN and if so, what should we be doing differently? In this episode we’ll be... | 23m 31s | ||||||
| 1/8/26 | Trailer Tubulointerstitial nephritis – the Cinderella of nephrology, Chronic kidney disease of unknown etiology, Treatment of obesity in patients with CKD | No description provided. | 1m 54s | ||||||
Showing 25 of 133
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for A pinch of salt - A podcast by ERA
Peaked at #78 in Ireland, currently #78 in Ireland.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Ireland | — | #78 | #78 | — |
| RO | — | #141 | #141 | — |
| Denmark | — | #146 | #146 | — |
| GR | — | #155 | #155 | — |
Chart Positions
4 placements across 4 markets.
Chart Positions
4 placements across 4 markets.